After finishing at $4.54 in the prior trading day, Allogene Therapeutics Inc (NASDAQ: ALLO) closed at $4.63, up 1.98%. In other words, the price has increased by $+0.0900 from its previous closing price. On the day, 2636558 shares were traded.
Ratios:
Our goal is to gain a better understanding of ALLO by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.58 and its Current Ratio is at 12.58. In the meantime, Its Debt-to-Equity ratio is 0.17 whereas as Long-Term Debt/Eq ratio is at 0.15.
On December 08, 2023, Citigroup started tracking the stock assigning a Buy rating and target price of $7.Citigroup initiated its Buy rating on December 08, 2023, with a $7 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 18 when MESSEMER DEBORAH M. sold 18,640 shares for $2.70 per share. The transaction valued at 50,317 led to the insider holds 62,456 shares of the business.
Mayo Stephen sold 10,000 shares of ALLO for $42,855 on Aug 07. The Director now owns 25,328 shares after completing the transaction at $4.29 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALLO now has a Market Capitalization of 779.12M and an Enterprise Value of 388.57M. For the stock, the TTM Price-to-Sale (P/S) ratio is 4100.72 while its Price-to-Book (P/B) ratio in mrq is 1.34. Its current Enterprise Value per Revenue stands at 2.17k whereas that against EBITDA is -1.24.
Stock Price History:
Over the past 52 weeks, ALLO has reached a high of $7.14, while it has fallen to a 52-week low of $2.23. The 50-Day Moving Average of the stock is 3.5394, while the 200-Day Moving Average is calculated to be 3.9889.
Shares Statistics:
The stock has traded on average 3.09M shares per day over the past 3-months and 2.13M shares per day over the last 10 days, according to various share statistics. A total of 144.44M shares are outstanding, with a floating share count of 103.86M. Insiders hold about 38.28% of the company’s shares, while institutions hold 61.11% stake in the company. Shares short for ALLO as of Jan 31, 2024 were 23.09M with a Short Ratio of 7.47, compared to 31.32M on Dec 29, 2023. Therefore, it implies a Short% of Shares Outstanding of 13.72% and a Short% of Float of 20.20%.
Earnings Estimates
Its stock is currently analyzed by 16 different market analysts. On average, analysts expect EPS of -$0.45 for the current quarter, with a high estimate of -$0.34 and a low estimate of -$0.62, while EPS last year was -$0.66. The consensus estimate for the next quarter is -$0.44, with high estimates of -$0.33 and low estimates of -$0.64.
Analysts are recommending an EPS of between -$1.89 and -$2.18 for the fiscal current year, implying an average EPS of -$2.01. EPS for the following year is -$1.76, with 17 analysts recommending between -$1.36 and -$2.4.
